Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-22.71%Return on Equity
VS
Market
Sector
Industry
History
$ 2.3Close
$ 1.36 - $ 6.35 52-Week Range
Ticker Information
Ticker
CYCNCompany Name
CYCLERION THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYCLERION THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CYCN - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 8.57M | $ -1.95M | -22.71% |
| 3/31/2025 | $ 8.78M | $ -2.94M | -33.53% |
| 12/31/2024 | $ 8.85M | $ -3.06M | -34.54% |
| 9/30/2024 | $ 8.2M | $ -5.28M | -64.42% |
| 6/30/2024 | $ 8.78M | $ 3.01M | 34.25% |
| 3/31/2024 | $ 9.92M | $ 149K | 1.5% |
| 12/31/2023 | $ 11.29M | $ -5.26M | -46.62% |
| 9/30/2023 | $ 12.87M | $ -10.79M | -83.78% |
| 6/30/2023 | $ 5.15M | $ -28.85M | -560.14% |
| 3/31/2023 | $ 3.92M | $ -38.05M | -969.53% |
Key Performance Insights, Last 5 Years
- CYCLERION THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -112.31%.
- Over the past 5 years, CYCLERION THERAPEUTICS INC's average ROE has been -176.29%.
- The median ROE for CYCLERION THERAPEUTICS INC during this period was -106.82%
- CYCLERION THERAPEUTICS INC reached its highest ROE over the past 5 years at 34.25%.
- The lowest ROE recorded by CYCLERION THERAPEUTICS INC in the same timeframe -969.53%
CYCLERION THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CYCLERION THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -84.63M ] / Equity [ $ 75.35M ]
(=) ROE [ -112.31% ] CYCN - Return on Equity, Last 5 years
-969.53%
Minimum
Mar 31, 2023
34.25%
Maximum
Jun 30, 2024
-176.29%
Average
-106.82%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |